|
RQCD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.202240E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.3626999999915E-05 |
| Normal-vs-Stage2 |
1.173240E-01 |
| Normal-vs-Stage3 |
5.152200E-01 |
| Normal-vs-Stage4 |
4.224600E-01 |
| Stage1-vs-Stage2 |
4.663600E-01 |
| Stage1-vs-Stage3 |
1.031810E-02 |
| Stage1-vs-Stage4 |
4.982300E-02 |
| Stage2-vs-Stage3 |
3.076800E-01 |
| Stage2-vs-Stage4 |
4.531400E-01 |
| Stage3-vs-Stage4 |
8.228000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.379100E-04 |
| Normal-vs-AfricanAmerican |
5.913600E-01 |
| Normal-vs-Asian |
1.417030E-01 |
| Caucasian-vs-AfricanAmerican |
1.720160E-02 |
| Caucasian-vs-Asian |
2.454800E-01 |
| AfricanAmerican-vs-Asian |
5.517800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.063500E-02 |
| Normal-vs-Female |
2.43829999999612E-05 |
| Male-vs-Female |
3.197000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.312400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.261670E-03 |
| Normal-vs-Age(61-80Yrs) |
1.019620E-02 |
| Normal-vs-Age(81-100Yrs) |
7.391800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.057400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.644200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.839400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.669200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.485400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.072800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.248000E-02 |
| Normal-vs-Grade 2 |
9.800900000001E-05 |
| Normal-vs-Grade 3 |
8.910400E-02 |
| Normal-vs-Grade 4 |
6.277400E-01 |
| Grade 1-vs-Grade 2 |
2.967200E-01 |
| Grade 1-vs-Grade 3 |
1.056980E-01 |
| Grade 1-vs-Grade 4 |
9.268300E-02 |
| Grade 2-vs-Grade 3 |
5.783800E-02 |
| Grade 2-vs-Grade 4 |
4.545700E-02 |
| Grade 3-vs-Grade 4 |
5.427800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.58840002157024E-09 |
| Normal-vs-ccB subtype |
1.949810E-01 |
| ccA subtype-vs-ccB subtype |
5.74899999999934E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.163390E-03 |
| Normal-vs-N1 |
5.687200E-01 |
| N0-vs-N1 |
7.560800E-01 |
|
|
